HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Joungho Han Selected Research

Bronchiolo-Alveolar Adenocarcinoma (Adenocarcinoma, Bronchiolo Alveolar)

6/2010FDG-PET/CT imaging in assessing mucin-producing non-small cell lung cancer with pathologic correlation.
10/2005Lobar mucinous bronchioloalveolar carcinoma of the lung showing negative FDG uptake on integrated PET/CT.
11/2004T1 non-small cell lung cancer: imaging and histopathologic findings and their prognostic implications.
9/2003Prognostic significance of E-cadherin and beta-catenin in resected stage I non-small cell lung cancer.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Joungho Han Research Topics

Disease

59Neoplasms (Cancer)
06/2022 - 07/2003
39Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung)
07/2022 - 09/2003
24Adenocarcinoma
10/2020 - 09/2003
23Lung Neoplasms (Lung Cancer)
06/2022 - 09/2003
16Adenocarcinoma of Lung
06/2020 - 02/2010
12Squamous Cell Carcinoma (Epidermoid Carcinoma)
01/2019 - 09/2003
9Carcinoma (Carcinomatosis)
12/2021 - 10/2004
7Neoplasm Metastasis (Metastasis)
11/2020 - 10/2004
5Disease Progression
01/2022 - 09/2007
4Interstitial Lung Diseases (Interstitial Lung Disease)
01/2022 - 10/2002
4Sarcoma (Soft Tissue Sarcoma)
01/2018 - 02/2014
4Small Cell Lung Carcinoma (Small Cell Lung Cancer)
01/2016 - 08/2006
4Mesothelioma
12/2014 - 12/2004
4Bronchiolo-Alveolar Adenocarcinoma (Adenocarcinoma, Bronchiolo Alveolar)
06/2010 - 09/2003
3Ankylosing Spondylitis
01/2022 - 10/2002
3Rheumatoid Arthritis
01/2022 - 10/2002
3Mixed Connective Tissue Disease (MCTD)
01/2022 - 10/2002
3Dermatomyositis (Dermatopolymyositis)
01/2022 - 10/2002
3Polymyositis
01/2022 - 10/2002
3Systemic Lupus Erythematosus (Libman-Sacks Disease)
01/2022 - 10/2002
3Bronchiectasis
01/2021 - 09/2012
3Idiopathic Pulmonary Fibrosis
01/2021 - 10/2002
3Carcinogenesis
01/2019 - 01/2013
3Myasthenia Gravis
01/2019 - 09/2007
3Thymoma (Thymic Carcinoma)
01/2019 - 09/2007
3Malignant Mesothelioma
12/2014 - 10/2012
3Lung Injury
12/2013 - 05/2005
3Esophageal Squamous Cell Carcinoma
02/2010 - 05/2006
2Sjogren's Syndrome (Sjogren Syndrome)
01/2022 - 01/2021
2Connective Tissue Diseases (Connective Tissue Disease)
01/2022 - 01/2021
2Wilms Tumor (Wilm's Tumor)
12/2021 - 04/2014
2Lung Diseases (Lung Disease)
01/2021 - 02/2007
2Diffuse Scleroderma (Progressive Systemic Sclerosis)
01/2021 - 10/2002
2Teratoma (Teratoid Tumor)
01/2019 - 08/2015
2Cryptogenic Organizing Pneumonia
01/2018 - 10/2002
2Necrosis
11/2015 - 12/2012
2Lymphangioleiomyomatosis (Lymphangiomyomatosis)
06/2014 - 04/2003
2Cysts
02/2014 - 11/2004
2Sarcoidosis (Schaumann Disease)
02/2014 - 01/2010
2Carcinoid Tumor (Carcinoid)
01/2010 - 11/2004
2Renal Insufficiency (Renal Failure)
06/2007 - 05/2007

Drug/Important Bio-Agent (IBA)

15Anaplastic Lymphoma KinaseIBA
10/2020 - 06/2013
11Proteins (Proteins, Gene)FDA Link
12/2021 - 02/2010
10ErbB Receptors (EGF Receptor)IBA
06/2022 - 02/2010
10Biomarkers (Surrogate Marker)IBA
01/2022 - 06/2004
9Messenger RNA (mRNA)IBA
06/2020 - 09/2006
8MucinsIBA
07/2019 - 10/2005
6ParaffinIBA
06/2015 - 09/2003
5DNA (Deoxyribonucleic Acid)IBA
01/2022 - 09/2006
5Tyrosine Kinase InhibitorsIBA
01/2019 - 07/2016
5Cadherins (E-Cadherin)IBA
01/2015 - 09/2003
5SmokeIBA
02/2009 - 06/2004
4ChromatinIBA
02/2021 - 07/2015
4Cisplatin (Platino)FDA LinkGeneric
09/2020 - 09/2008
4CrizotinibIBA
07/2019 - 03/2014
4Biological ProductsIBA
01/2019 - 04/2003
4Fluorodeoxyglucose F18 (Fludeoxyglucose F 18)FDA Link
01/2018 - 12/2007
4Formaldehyde (Formol)FDA Link
06/2015 - 01/2013
3Adrenal Cortex Hormones (Corticosteroids)IBA
01/2022 - 09/2004
3Histones (Histone)IBA
02/2021 - 12/2015
3Metformin (Glucophage)FDA LinkGeneric
02/2021 - 11/2017
3Small Interfering RNA (siRNA)IBA
02/2021 - 12/2015
3CateninsIBA
09/2020 - 01/2015
3PlatinumIBA
01/2019 - 09/2008
3Cyclin D1IBA
12/2016 - 01/2015
3Thymidylate SynthaseIBA
08/2015 - 09/2010
3Pemetrexed (MTA)FDA Link
08/2015 - 09/2010
3AsbestosIBA
04/2014 - 01/2006
3Histidine (L-Histidine)FDA Link
05/2006 - 06/2004
3H-cadherin (T-cadherin)IBA
04/2006 - 06/2004
2Indicators and Reagents (Reagents)IBA
03/2022 - 06/2020
2beta-cyclodextrin tetradecasulfate (CTDS)IBA
01/2022 - 01/2021
2Thyroid Nuclear Factor 1IBA
12/2021 - 08/2011
2Nuclear Proteins (Protein, Nuclear)IBA
11/2020 - 09/2018
2osimertinibIBA
11/2020 - 01/2016
2Antineutrophil Cytoplasmic Antibodies (ANCA)IBA
01/2019 - 05/2010
2AcidsIBA
01/2019 - 02/2007
2Colloids (Colloid)IBA
12/2018 - 01/2018
2CollagenIBA
10/2017 - 10/2002
2Mucin-1 (CA 15-3 Antigen)IBA
12/2014 - 03/2006
2lipoarabinomannan (LAM)IBA
06/2014 - 04/2003
2Phosphotransferases (Kinase)IBA
03/2014 - 03/2014
2Immunoglobulins (Immunoglobulin)IBA
01/2014 - 10/2011
2S100 Proteins (S 100 Protein)IBA
08/2013 - 03/2006

Therapy/Procedure

15Therapeutics
07/2022 - 10/2005
8Drug Therapy (Chemotherapy)
01/2019 - 09/2003
6Chemoradiotherapy
04/2019 - 12/2003
4Adjuvant Chemotherapy
09/2020 - 04/2014
3Traction
01/2021 - 09/2012
3Lymph Node Excision (Lymph Node Dissection)
02/2015 - 09/2005
3Artificial Respiration (Mechanical Ventilation)
12/2013 - 05/2005
2Aftercare (After-Treatment)
01/2019 - 01/2005
2Radiotherapy
07/2015 - 09/2003
2Stents
06/2014 - 08/2010
2Pneumonectomy (Lung Volume Reduction)
04/2014 - 12/2013
2Neoadjuvant Therapy
01/2014 - 04/2012
2Positive-Pressure Respiration (Positive End-Expiratory Pressure)
12/2013 - 05/2005
2Operative Surgical Procedures
10/2012 - 07/2007
2Thymectomy
06/2010 - 09/2007
2Esophagectomy
02/2010 - 05/2006